PROTHROMBIN COMPLEX CONCENTRATE FOR RAPID REVERSAL OF WARFARIN-INDUCED ANTICOAGULATION AND INTRACEREBRAL HEMORRHAGE IN PATIENTS SUPPORTED BY A LEFT VENTRICULAR ASSIST DEVICE

被引：7

作者：

Takahashi, Ayako ^{[1
]}

Kato, Tomoko S. ^{[1
,2
]}

Oda, Noboru ^{[1
,2
]}

Komamura, Kazuo ^{[1
,2
]}

Kanzaki, Hideaki ^{[1
]}

Asakura, Masaki ^{[1
]}

Hashimura, Kazuhiko ^{[1
]}

Niwaya, Kazuo ^{[3
]}

Funatsu, Toshiaki ^{[3
]}

Nakatani, Takeshi ^{[2
]}

Kobayashi, Junjiro ^{[3
]}

Kitamura, Soichiro ^{[3
]}

Shishido, Toshiaki ^{[4
]}

Miyata, Shigeki ^{[5
]}

Takahashi, Jun C. ^{[6
]}

Iihara, Koji ^{[6
]}

Kitakaze, Masafumi ^{[1
]}

机构：

[1] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka 5658565, Japan

[2] Natl Cerebral & Cardiovasc Ctr, Dept Organ Transplantat, Osaka 5658565, Japan

[3] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Osaka 5658565, Japan

[4] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, Osaka 5658565, Japan

[5] Natl Cerebral & Cardiovasc Ctr, Dept Blood Transfus, Osaka 5658565, Japan

[6] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Osaka 5658565, Japan

来源：

INTERNATIONAL JOURNAL OF GERONTOLOGY | 2010年 / 4卷 / 03期

关键词：

anticoagulants; cerebral hemorrhage; heart-assist devices; heart transplantation; prothrombin complex concentrate; INTRACRANIAL HEMORRHAGE; FACTOR VIIA; THERAPY; MANAGEMENT;

D O I：

10.1016/S1873-9598(10)70038-7

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Background: Intracerebral hemorrhage (ICH) is one of the most serious complications in patients supported by a left ventricular assist device (LVAD). We evaluate the efficacy of prothrombin complex concentrate (PCC) for rapid reversal of warfarin-induced anticoagulation in this population. Methods: A total of 38 consecutive ICH events in patients supported by an LVAD between 1996 and 2007 were retrospectively reviewed. Fourteen ICH events were treated with fresh frozen plasma (FFP) (Group FFP) and 24 ICH events were treated with PCC (Group PCC). The efficacy and outcome of PCC administration versus FFP were evaluated. Results: The proportion of patients surviving after an ICH event was significantly smaller in Group FFP than Group PCC (35.7% vs. 75.0%, p<0.05). None of the patients in Group FFP were able to undergo heart transplantation, whereas 21.4% patients in Group PCC successfully underwent heart transplantation. Conclusion: Patients on LVAD are in need for intensified anticoagulation and are at high risk of ICH; therefore, adequate use of PCC in the event of ICH could be of importance for survival and allow subsequent heart transplantation. [International Journal of Gerontology 2010; 4(3): 143-147]

引用

页码：143 / 147

页数：5

共 50 条

[41] Rapid reversal of the oral anticoagulation effect using a prothrombin complex concentrate (PCC).
Sowade, O
Lorenz, R
Otto, U
Kwasny, H
Egger, K
Schreiter, D
Dobrkovská, A
Barthels, M
BLOOD, 1998, 92 (10) : 110B - 110B
[42] Efficacy and safety of a prothrombin complex concentrate (Octaplex®) for rapid reversal of oral anticoagulation
Lubetsky, A
Hoffman, R
Zimlichman, R
Eldor, A
Zvi, J
Kostenko, V
Brenner, B
THROMBOSIS RESEARCH, 2004, 113 (06) : 371 - 378
[43] Reversal of warfarin anticoagulation using prothrombin complex concentrate at 25 IU kg-1: results of the RAPID study
Appleby, N.
Groarke, E.
Crowley, M.
Wahab, F. A.
McCann, A. M.
Egan, L.
Gough, D.
McMahon, G.
O'Donghaile, D.
O'Keeffe, D.
O'Connell, N.
TRANSFUSION MEDICINE, 2017, 27 (01) : 66 - 71
[44] Fixed-dose prothrombin complex concentrate for emergent warfarin reversal among patients with intracranial hemorrhage
Dietrich, Scott K.
Mixon, Mark A.
Rech, Megan A.
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 49 : 326 - 330
[45] Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate
Peksa, Gary D.
Mokszycki, Robert K.
Rech, Megan A.
Maynard, Brian
Panos, Nicholas G.
Sweis, Rolla T.
DeMott, Joshua M.
THROMBOSIS AND HAEMOSTASIS, 2020, 120 (02) : 207 - 215
[46] Temporarily Reversing Warfarin With Low-Dose 4-Factor Prothrombin Complex Concentrate in Left Ventricular Assist Device Patients Undergoing an Invasive Procedure
Stevenson, Byron
Roberts, A. Joshua
Dager, William E.
ANNALS OF PHARMACOTHERAPY, 2025, 59 (01) : 5 - 12
[47] Activated Prothrombin Complex Concentrate versus Plasma for Reversal of Warfarin-Associated Hemorrhage
Rowe, Anthony Shaun
Mahbubani, Pinky S.
Bucklin, Mason H.
Clark, Christopher T.
Hamilton, Leslie A.
PHARMACOTHERAPY, 2016, 36 (11): : 1132 - 1137
[48] Prothrombin Complex Concentrate Use in Durable and Short-Term Left Ventricular Assist Device Implantation
Barac, Yaron D.
Nevo, Adam
Jawitz, Oliver
Hashmi, Nazish K.
Henkel, Peter
Blue, Laura J.
Kelly, Joseph
Patel, Chetan B.
Daneshmand, Mani A.
Schroder, Jacob N.
Milano, Carmelo A.
Welsby, Ian
ASAIO JOURNAL, 2020, 66 (01) : E8 - E10
[49] Neurosurgical Management in Left Ventricular Assist Device (LVAD) Patients With Intracerebral Hemorrhage (ICH)
Mueller, Kyle
D'Antuono, Matthew R.
Zhao, David
Mai, Jeffrey C.
Aulisi, Edward F.
Felbaum, Daniel
Hockstein, Michael
Armonda, Rocco
NEUROSURGERY, 2019, 66 : 148 - 148
[50] A retrospective analysis of anticoagulation reinstitution in patients with left ventricular assist device who developed intracerebral hemorrhage at Mayo Clinic Arizona
Dawit, S.
Santos, C.
Matos, N.
Freeman, W.
O'carroll, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 374 - 374

← 1 2 3 4 5 →